Micro & Nanomédecines Translationelles-MINT, UNIV Angers, INSERM U1066, CNRS UMR 6021, UBL Université Bretagne Loire, Angers F-49933, France.
Micro & Nanomédecines Translationelles-MINT, UNIV Angers, INSERM U1066, CNRS UMR 6021, UBL Université Bretagne Loire, Angers F-49933, France.
Int J Pharm. 2017 Dec 20;534(1-2):220-228. doi: 10.1016/j.ijpharm.2017.10.017. Epub 2017 Oct 14.
The aim of the present study was to optimize the size and polydispersity of a lipid nanoemulsion as a function of the oil (Labrafac WL1349), surfactant (Kolliphor HS 15) and cosurfactant (Span 80) phase composition and temperature. The nanoemulsions were prepared using a low-energy self-emulsification method. The Z-average diameter and the polydispersity index (PDI) were modeled with mixture experiments. Nanoemulsions from 20nm to 120nm with PDI<0.2 were obtained at the three different tested temperatures (30°C, 50°C and 90°C). The nanoemulsion size was able to be controlled with the oil, surfactant and cosurfactant concentrations. Interestingly, the smallest PDIs were obtained at 30°C, and the cosurfactant concentration was able to be adjusted to optimize the formulation and to obtain nanoemulsions in the 20-120nm range with a PDI smaller than 0.14. These nanoemulsions have shown a good stability at 4°C in storage conditions and at 37°C in diluted conditions.
本研究的目的是优化脂质纳米乳的粒径和多分散性,这取决于油相(Labrafac WL1349)、表面活性剂(Kolliphor HS 15)和助表面活性剂(Span 80)的组成和温度。纳米乳是通过低能量自乳化法制备的。使用混合物实验对 Z 均粒径和多分散指数(PDI)进行建模。在三个不同的测试温度(30°C、50°C 和 90°C)下,得到了粒径在 20nm 到 120nm 之间、PDI<0.2 的纳米乳。纳米乳的粒径可以通过油相、表面活性剂和助表面活性剂的浓度来控制。有趣的是,在 30°C 下获得了最小的 PDI,并且可以调整助表面活性剂的浓度以优化配方,从而在 20-120nm 范围内获得 PDI 小于 0.14 的纳米乳。这些纳米乳在 4°C 的储存条件下和在 37°C 的稀释条件下都表现出良好的稳定性。